Vaxxinity Stock Today
| VAXX Stock | USD 0.20 0.07 25.93% |
Performance0 of 100
| Odds Of DistressOver 85
|
Vaxxinity is trading at 0.2 as of the 24th of April 2024; that is -25.93 percent decrease since the beginning of the trading day. The stock's open price was 0.27. Vaxxinity has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Vaxxinity are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of November 2021 | Category Healthcare | Classification Health Care |
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 112.87 M outstanding shares of which 4.08 M shares are at this time shorted by private and institutional investors with about 7.87 trading days to cover. More on Vaxxinity
Moving together with Vaxxinity Stock
| 0.85 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Vaxxinity Stock
| 0.79 | ELYM | Eliem Therapeutics | PairCorr |
| 0.41 | ITCI | Intracellular Th Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 14th of May 2024
Vaxxinity Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vaxxinity's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaxxinity or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Vaxxinity report their recommendations after researching Vaxxinity's financial statements, talking to executives and customers, or listening in on Vaxxinity's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Vaxxinity. The Vaxxinity consensus assessment is calculated by taking the average forecast from all of the analysts covering Vaxxinity. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Vaxxinity's financial statements, Vaxxinity is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Vaxxinity is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Vaxxinity's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vaxxinity's financial leverage. It provides some insight into what part of Vaxxinity's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity (VAXX) is traded on NASDAQ Exchange in USA. It is located in 505 Odyssey Way, Merritt Island, FL, United States, 32953 and employs 57 people. Vaxxinity is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vaxxinity's market, we take the total number of its shares issued and multiply it by Vaxxinity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vaxxinity conducts business under Biotechnology sector and is part of Health Care industry. The entity has 112.87 M outstanding shares of which 4.08 M shares are at this time shorted by private and institutional investors with about 7.87 trading days to cover.
Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Vaxxinity Probability Of Bankruptcy
Ownership AllocationVaxxinity shows a total of 112.87 Million outstanding shares. Vaxxinity maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vaxxinity Ownership Details
Vaxxinity Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Vaxxinity jumping above the current price in 90 days from now is close to 99%. The Vaxxinity probability density function shows the probability of Vaxxinity stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Vaxxinity has a beta of 0.1972. This entails as returns on the market go up, Vaxxinity average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vaxxinity will be expected to be much smaller as well. Additionally, vaxxinity has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Vaxxinity to move above the current price in 90 days from now is close to 99 (This Vaxxinity probability density function shows the probability of Vaxxinity Stock to fall within a particular range of prices over 90 days) .
Vaxxinity Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Vaxxinity that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vaxxinity's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vaxxinity's value.| Instituion | Recorded On | Shares | |
| Pathstone Holdings Llc | 2023-12-31 | 153.8 K | |
| Pathstone Family Office, Llc | 2023-09-30 | 153.8 K | |
| Scoggin Llc | 2023-09-30 | 150 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 120.7 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 120.3 K | |
| Ieq Capital, Llc | 2023-12-31 | 83.3 K | |
| Mcadam, Llc | 2023-12-31 | 78.3 K | |
| Barclays Plc | 2023-12-31 | 58.5 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 58 K | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 3 M | |
| Blackrock Inc | 2023-12-31 | 2.7 M |
Vaxxinity Historical Income Statement
Vaxxinity Income Statement is one of the three primary financial statements used for reporting Vaxxinity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Vaxxinity revenue and expense. Vaxxinity Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Vaxxinity's Net Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to rise to about 2.3 M in 2024, whereas Interest Expense is likely to drop slightly above 586.6 K in 2024. View More FundamentalsVaxxinity Stock Against Markets
Picking the right benchmark for Vaxxinity stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vaxxinity stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vaxxinity is critical whether you are bullish or bearish towards Vaxxinity at a given time. Please also check how Vaxxinity's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vaxxinity without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Vaxxinity Corporate Management
Elected by the shareholders, the Vaxxinity's board of directors comprises two types of representatives: Vaxxinity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vaxxinity. The board's role is to monitor Vaxxinity's management team and ensure that shareholders' interests are well served. Vaxxinity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vaxxinity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter MD | Global VP | Profile | |
| Louis IV | CoFounder Chairman | Profile | |
| Jon Harrison | Chief Officer | Profile | |
| Mei JD | CEO Director | Profile | |
| Ulo MD | Chief Officer | Profile | |
| Benjamin Matone | VP Relations | Profile | |
| Mark Joinnides | Chief Staff | Profile |
How to buy Vaxxinity Stock?
Before investing in Vaxxinity, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vaxxinity. To buy Vaxxinity stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vaxxinity. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vaxxinity stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vaxxinity stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vaxxinity stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vaxxinity, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.
Already Invested in Vaxxinity?
The danger of trading Vaxxinity is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vaxxinity is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vaxxinity. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vaxxinity is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vaxxinity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaxxinity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaxxinity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaxxinity Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxxinity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Vaxxinity Stock analysis
When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Vaxxinity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxxinity. If investors know Vaxxinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxxinity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Quarterly Revenue Growth (0.57) | Return On Assets (0.48) | Return On Equity (1.51) |
The market value of Vaxxinity is measured differently than its book value, which is the value of Vaxxinity that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxxinity's value that differs from its market value or its book value, called intrinsic value, which is Vaxxinity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxxinity's market value can be influenced by many factors that don't directly affect Vaxxinity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxxinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxxinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxxinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.